Michael A. Wheeler: Psychedelics and neuroimmune circuits—what a strange trip, indeed

In a thought-provoking Genomic Press interview, Dr. Michael Wheeler emerges as a brilliant scientific innovator at the intersection of neuroscience and immunology. As an Assistant Professor at Harvard Medical School and an investigator at Brigham and Women's Hospital, Wheeler's groundbreaking research explores how brain-immune communication shapes our behaviors and emotions. His innovative laboratory weaves together genomic screening, single-cell technologies, and behavioral studies to unravel the fascinating dialogue between peripheral immune cells and brain function. Most remarkably, Wheeler's NIH-funded research has shown that psychedelics like psilocybin can reverse stress-induced fear behaviors by targeting a previously hidden neuroimmune pathway connecting inflammatory cells in the meninges to critical brain regions controlling emotions and rewards. This groundbreaking work has just been further validated in a Nature article (23 April 2025, DOI: 10.1038/s41586-025-08880-9 ) showing how psychedelics regulate the complex interplay between brain and immune cells in fear responses. By revealing how psychedelics modulate not just neurons but also immune responses, Wheeler's paradigm-shifting research opens exciting new therapeutic possibilities for depression, addiction, and stress-related disorders. Through his warm, authentic scientific approach and deep curiosity about mind-body connections, Wheeler represents a new generation of researchers redrawing the boundaries between psychiatry and immunology to transform our understanding of mental health.